MaineGeneral Medical Center Competency Based Orientation Tool RN Staff Care of the Patient Receiving Intraperitoneal Chemotherapy

Size: px
Start display at page:

Download "MaineGeneral Medical Center Competency Based Orientation Tool RN Staff Care of the Patient Receiving Intraperitoneal Chemotherapy"

Transcription

1 MaineGeneral Medical Center Competency Based Orientation Tool RN Staff Care of the Patient Receiving Intraperitoneal Chemotherapy Scale: 3 = met: knowledgeable and able to perform independently. 2* = Knowledgeable: continued need for practice. 1* = Needs review, practice and supervision. *All scores of 1 and 2: should be communicated to the new employee s manager for follow up. Performance Scale: The Evaluating Nurse will initial and date upon completion of the task/criteria. Key Considerations: The goal is consistency with education and competency evaluation. Identify an individual preceptor for each newly hired RN/New Graduate to instruct and review performance. New Employees must complete the self-assessment prior to beginning clinical orientation. Preceptors must review the self-assessment with the new employee. New employees may not perform identified competencies until verified by the preceptor. Length of orientation process to be identified and agreed upon by preceptor and orientee, and Manager. Unit scheduling should be established to support successful orientation and socialization to role. Preceptor(s) Initials Signature Initials Signature Orientee revised: May 2007, SMC & N.Tar 1

2 MaineGeneral Medical Center Registered Nurse Competency Based Orientation Tool Oncology Service Line Care of the Patient Receiving Intraperitoneal Chemotherapy Name: Unit: Clinical Competency Prior to Administration Policy # MM-37: Administration of Intraperitoneal Antineoplastics Preceptor instruction, 1. Familiarizes self with agents Reviews patient s allergy history Assesses patient s response to previous therapy 4. Verifies that consent for treatment is signed 5. Checks that laboratory values are within acceptable parameters and reports results to MD/PA as needed - Absolute Neutrophil Count - CBC-Diff - Electrolytes - Renal Function Tests

3 6. Verifies written order with patient profile Recalculates drug doses Checks chemotherapy order for drug, dose, route, rate, schedule (Cycle # and day), and mode of administration 9. Verifies that patient education, premedication, prehydration, and other preparations are completed Intraperitoneal Administration Policy # MM-37: Administration of Intraperitoneal Antineoplastics Review Article: Management of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer Preceptor instruction, 1. Compares original order to delivered drug (checks with second RN) Verifies patient identification Provides pre-medication/ prehydration, if indicated

4 4. Assembles appropriate supplies Assesses the area around the port for - Redness - Edema - Warmth - Tenderness - Infection - Leakage 6. Accesses implanted port using - Aseptic technique - 19-gauge non-coring needle of appropriate length Withdraws 10 ml of discard Flushes the port with 20 ml of Normal Saline to ensure patency 9. Positions patient in a semi-fowler s position 10. Establishes a running line with warmed Normal Saline

5 11. Demonstrates safe-handling precautions - Drug spray or contact with skin or mucous membranes - Drug spill 11. Review Policy #PC-56: Precautionary Measures for Cytotoxic Agents Infuses the warmed IP chemotherapy at the prescribed rate - Usually over 30 minutes to several hours 13. Demonstrates safe administration via gravity infusion - Ensures appropriate rate of administration - Stops infusion immediately if severe pain is experienced - Slows the rate of infusion if the patient experiences - Shortness of breath - Discomfort

6 14. Demonstrates appropriate monitoring// management for specific acute drug effects - Myelosuppression - Neutropenia - Anemia - Thrombocytopenia - GI and Mucosal Side Effects - Nausea and Vomiting - Diarrhea - Mucositis - Anorexia - Constipation - Alopecia - Fatigue - Cardiac Toxicity - Pulmonary Toxicity - Hepatotoxicity - Nephrotoxicity - Neurotoxicity - Alterations in Sexuality and Reproductive Function - Peritonitis 15. Takes appropriate action in the event of hypersensitivity reaction 16. Repositions the patient from side to side every 15 minutes for 1 hour

7 After Administration Policy # MM-37: Administration of Intraperitoneal Antineoplastics Preceptor instruction, 1. Flushes port with 20 ml of Normal Saline, followed by 10 ml of Heparin (100 units/ml) 2. Appropriately removes non-coring needle 3. Disposes of chemotherapy waste according to procedure 4. Documents - Procedure - of site - Size of needle - Education - Patient response 5. Communicates post-treatment considerations to patient, family members, and appropriate personnel - How to contact clinic - Assure that patient has Rx and understands directions

8 Care of the Patient with an Intraperitoneal Port 1. Follows procedure for port access and maintenance 1. Review Procedure: Implanted Port, Accessing Review Procedure: Central Venous Access Devices Dressing Changes Review Policy# PC-07: Line Therapy Preceptor instruction, States measures to take in the event of complications - Access difficulty - Catheter fragment - Catheter migration - Fibrin sheath - Infection - Kinking of catheter - Occlusion - Retrograde flow of infusate into port pocket 2. Review Article: Management of Intraperitoneal Chemotherapy for Treatment of Ovarian Cancer 2. Patient Education Preceptor instruction, 1. Provides education related to the drug administration process, side effects of the drug, side effects of the route, and measures to manage/minimize the side effects

9 Written 1/24/07 TLP 9

Eliminating Infusion Confusion

Eliminating Infusion Confusion Eliminating Infusion Confusion (Drug Administrations in Non-facility Settings) Maryann C. Palmeter, CPC, CENTC Agenda Review of CPT codes (added in 2009) Documentation principles Key definitions What s

More information

Physician Orders - Adult

Physician Orders - Adult Physician Orders - Adult attach patient label here Title: Direct Thrombin Inhibitor (DTI) Protocol Orders Height: cm Weight: kg Allergies: [ ] No known allergies [ ]Medication allergy(s): [ ] Latex allergy

More information

Comfort your patient deserves. Strength you demand.

Comfort your patient deserves. Strength you demand. POLYSITE LOW PROFILE HYBRID PORTS Comfort your patient deserves. Strength you demand. We never settle because you never settle. Throughout our 35-year history, clinicians and patients have benefited from

More information

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE

A GUIDE TO THIS REFLECTIONS B RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE A GUIDE TO THIS REFLECTIONS B327-02 RESEARCH STUDY IF YOU RE FIGHTING BREAST CANCER, YOU RE NOT ALONE Do you have breast cancer that has spread to outside the breast? Has your tumor tested positive for

More information

Pharmacy. Medication. Checks

Pharmacy. Medication. Checks Pharmacy Medication Checks Module 2 Table of Contents Section A... 1 A.1 Clinical Medication Order Check... 1 A.2 Final Product and Computer Order Entry Check... 1 Section B... 2 B.1 Documentation of Pharmacy

More information

Media Release Medienmitteilung Communiqué Aux Médias

Media Release Medienmitteilung Communiqué Aux Médias Sandoz launches Zarxio TM (filgrastim-sndz), the first biosimilar in the United States Launch follows March 6, 2015 FDA approval Sandoz One Source TM offers patient support services Holzkirchen, September

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Patient Case and Question

Patient Case and Question Management of Multiple Myeloma: The Changing Paradigm Relapsed/Refractory Disease Kenneth H. Shain, MD, PhD Assistant Member H. Lee Moffitt Cancer Center Assistant Professor University of South Florida

More information

Bevyxxa (betrixaban) NEW PRODUCT SLIDESHOW

Bevyxxa (betrixaban) NEW PRODUCT SLIDESHOW Bevyxxa (betrixaban) NEW PRODUCT SLIDESHOW Introduction Brand name: Bevyxxa Generic name: Betrixaban Pharmacological class: Factor Xa inhibitor Strength and Formulation: 40mg, 80mg; caps Manufacturer:

More information

Treatment strategies for relapsing and refractory myeloma

Treatment strategies for relapsing and refractory myeloma Treatment strategies for relapsing and refractory myeloma Dr Guy Pratt #MyelomaInfodays This talk will cover What is relapse and refractory myeloma Treatment options for relapse Treatment options for refractory

More information

Material Safety data sheet

Material Safety data sheet EMERGENCY OVERVIEW contain Ribaverin and excipients generally considered to be non- toxic and non-hazardous in small quantities and under conditions of normal occupational exposure. Section 1. Identification

More information

Doxorubicin Hydrochloride Liposome Injection

Doxorubicin Hydrochloride Liposome Injection Doxorubicin Hydrochloride Liposome Injection SECTION 1. Supplier of Data COMPANY AND MATERIAL IDENTIFICATION Getwell Pharmaceuticals 474, Udyog Vihar, Phase-V, Gurgaon - 122 016, Haryana, INDIA In case

More information

PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)

PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) INDICATION IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable

More information

**MATERIAL SAFETY DATA SHEET**

**MATERIAL SAFETY DATA SHEET** Date Issued: August 19, 2009 Version: 5.0 Supersedes: August 8, 2006 Page 1 of 5 Section 1 Product and Company Identification Product Name: Herceptin Chemical Name: Anti-p185 HER2 Chemical Family: High

More information

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin

Coordinated Primary Options Service. DVT Management Plan. Management options using Dabigatran or Warfarin Coordinated Primary Options Service DVT Management Plan Management options using Dabigatran or Warfarin Name NHI DOB Ethnicity Gender Address Contact Information Mobile Home Treatment commenced date *CPO

More information

FREQUENTLY ASKED QUESTIONS

FREQUENTLY ASKED QUESTIONS ZARXIO FORMULARY INFORMATION FREQUENTLY ASKED QUESTIONS INDICATIONS: Patients with Cancer Receiving Myelosuppressive Chemotherapy ZARXIO is indicated to decrease the incidence of infection as manifested

More information

AMGEN SUBMITS APPLICATIONS IN THE US AND EUROPE FOR KYPROLIS (CARFILZOMIB) FOR THE TREATMENT OF RELAPSED MULTIPLE MYELOMA

AMGEN SUBMITS APPLICATIONS IN THE US AND EUROPE FOR KYPROLIS (CARFILZOMIB) FOR THE TREATMENT OF RELAPSED MULTIPLE MYELOMA January 29, 2015 ONO PHARMACEUTICAL CO., LTD. Corporate Communications public_relations@ono.co.jp AMGEN SUBMITS APPLICATIONS IN THE US AND EUROPE FOR KYPROLIS Amgen (NASDAQ:AMGN) and its subsidiary Onyx

More information

KLONOPIN(R) Tablets (2 mg)

KLONOPIN(R) Tablets (2 mg) Material Safety Data Sheet KLONOPIN(R) Tablets (2 mg) 1. Product and Company Identification Product name Product code Company information KLONOPIN(R) Tablets (2 mg) CSE-1159 Enquiries: Hoffmann-La Roche

More information

This talk will cover. Treatment for relapsed and/or refractory myeloma. What is relapsed myeloma and refractory myeloma. Treatment options for relapse

This talk will cover. Treatment for relapsed and/or refractory myeloma. What is relapsed myeloma and refractory myeloma. Treatment options for relapse This talk will cover Treatment for relapsed and/or refractory myeloma Dr Guy Pratt Consultant Haematologist Heart of England NHS Trust and Senior Lecturer in Haematology University of Birmingham What is

More information

Neutrophil support for patients with cancer receiving myelosuppressive chemotherapy

Neutrophil support for patients with cancer receiving myelosuppressive chemotherapy Appropriate dosing of NEUPOGEN in recovery of neutrophil counts in myelosuppressive regimens Neutrophil support for patients with cancer receiving myelosuppressive chemotherapy Indication NEUPOGEN is indicated

More information

Insertion of Skin Tunnelled Central Venous Catheter (STC)

Insertion of Skin Tunnelled Central Venous Catheter (STC) Insertion of Skin Tunnelled Central Venous Catheter (STC) This leaflet explains more about STC insertion, including the benefits, risks and any alternatives and what you can expect when you come to hospital.

More information

Package leaflet: Information for the user. HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion. Human albumin

Package leaflet: Information for the user. HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion. Human albumin Package leaflet: Information for the user HUMAN ALBUMIN BAXALTA 200 g/l Solution for Infusion Human albumin Read all of this leaflet carefully before you start using this medicine because it contains important

More information

Myeloma treatment algorithm 1999

Myeloma treatment algorithm 1999 Outlook for myeloma patients has improved Treatment for relapsed and/or refractory myeloma Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust Senior Lecturer, University of Birmingham

More information

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects.

Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Heparin Induced Thrombocytopenia. Temporal Aspects. Heparin Induced Eric Kraut, MD Professor of Internal Medicine The Ohio State University Medical Center Heparin Induced Heparin induced thrombocytopenia occurs in up to 5 % of patients receiving unfractionated

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

UNIT PRICING INFORMATION 1

UNIT PRICING INFORMATION 1 ZARXIO FORMULARY INFORMATION UNIT PRICING INFORMATION 1 TYPE OF INJECTABLE NATIONAL DRUG CODE (NDC) NUMBER UNIT QUANTITY UNIT PRICE (WAC) Single-dose preservative-free, prefilled syringes with an UltraSafe

More information

MIDLAND INDUSTRIES, INC N. HALSTED ST. CHICAGO, IL (312) (312) (313) FAX MATERIAL SAFETY DATA SHEET

MIDLAND INDUSTRIES, INC N. HALSTED ST. CHICAGO, IL (312) (312) (313) FAX MATERIAL SAFETY DATA SHEET MIDLAND INDUSTRIES, INC. 1424 N. HALSTED ST. CHICAGO, IL 606022 60622 (312)664-7300 (312) (313)664-7371 FAX MATERIAL SAFETY DATA SHEET I. MATERIAL IDENTIFICATION MATERIAL NAME: A.K.A.: ZINC ALLOY #5 ZINC

More information

PRODUCT MONOGRAPH. (filgrastim) Sterile Solution for Injection. (Subcutaneous or Intravenous Use Only) Hematopoietic Agent

PRODUCT MONOGRAPH. (filgrastim) Sterile Solution for Injection. (Subcutaneous or Intravenous Use Only) Hematopoietic Agent PRODUCT MONOGRAPH Pr Neupogen (filgrastim) Sterile Solution for Injection (Subcutaneous or Intravenous Use Only) 300 g/ml and 600 g/ml Hematopoietic Agent Granulocyte Colony Stimulating Factor Amgen Canada

More information

January (San Francisco, CA) January 8, 2018

January (San Francisco, CA) January 8, 2018 January 2017 J.P. Morgan 36 th Annual Management Healthcare Presentation Conference (San Francisco, CA) January 8, 2018 DISCLAIMER Certain information contained in this presentation relates to or is based

More information

Published 07 February 2011 Page January 2011

Published 07 February 2011 Page January 2011 filgrastim 12 million units (120microgram) / 0.2mL, 30 million units (300microgram) / 0.5mL, 48 million units (480microgram) / 0.5mL solution for injection/infusion in pre-filled syringe (Nivestim) SMC

More information

SAFETY DATA SHEET. Hair & Body Shampoo. DISTRIBUTOR 24 HR. EMERGENCY TELEPHONE NUMBERS IDC Corporation

SAFETY DATA SHEET. Hair & Body Shampoo. DISTRIBUTOR 24 HR. EMERGENCY TELEPHONE NUMBERS IDC Corporation 1. PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME: Hair & Body Shampoo GENERAL USE: For washing hair and body. PRODUCT DESCRIPTION: Hair & Body Shampoo CHEMICAL FAMILY: Detergent blend SAFETY DATA SHEET

More information

Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust. Natural course of myeloma. Some definitions. First relapse.

Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust. Natural course of myeloma. Some definitions. First relapse. Outlook for myeloma patients has improved Treatment for relapsed and/or refractory myeloma Dr Guy Pratt Consultant Haematologist, Heart of England NHS Foundation Trust Senior Lecturer, University of Birmingham

More information

SAFETY DATA SHEET. Pearl Creme. DISTRIBUTOR 24 HR. EMERGENCY TELEPHONE NUMBERS Clearfield Wholesale Paper Co.

SAFETY DATA SHEET. Pearl Creme. DISTRIBUTOR 24 HR. EMERGENCY TELEPHONE NUMBERS Clearfield Wholesale Paper Co. 1. PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME: Pearl Creme GENERAL USE: Hand cleaner PRODUCT DESCRIPTION: Pearlescent lotion hand soap CHEMICAL FAMILY: Detergent Blend SAFETY DATA SHEET Pearl Creme

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

LEARN. about. Please see Important Safety Information on pages 3-5 and enclosed full Prescribing Information.

LEARN. about. Please see Important Safety Information on pages 3-5 and enclosed full Prescribing Information. LEARN about on pages 3-5 and enclosed 2 3? What is ZARXIO (filgrastim-sndz)? ZARXIO is a man-made form of granulocyte colony-stimulating factor (G-CSF) called filgrastim. G-CSF is a substance produced

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 5 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

TRUFILL DCS ORBIT Detachable Coil System

TRUFILL DCS ORBIT Detachable Coil System ORBIT Conforming to Your Complex Needs Excellent Conformability and Concentric Filling for Outstanding Packing Density ORBIT Full range of Mini Complex and new Tight Distal Loop Technology coils Our Complex

More information

Safety Data Sheet European Format

Safety Data Sheet European Format Safety Data Sheet European Format 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Preparation Date 26-Jul-2007 Revision Date 09-Sep-2008 Revision Number 3 Product Name Common

More information

Published 13 June 2011 Page May 2011

Published 13 June 2011 Page May 2011 filgrastim, 30 million units (300 micrograms)/0.5ml, 48 million units (480 micrograms)/0.5ml, solution for injection or infusion in pre-filled syringe (Zarzio ) SMC No. (704/11) Sandoz Ltd 06 May 2011

More information

Content on this page requires a newer version of Adobe Flash Player.

Content on this page requires a newer version of Adobe Flash Player. Content on this page requires a newer version of Adobe Flash Player. 13-1-2018 IV vesicants and pain while a vesicant will cause tissue damage if it escapes. Ciprofloxacin is not designated as a vesicant

More information

Microsphere Brachytherapy Sources and Devices

Microsphere Brachytherapy Sources and Devices Microsphere Brachytherapy Sources and Devices REVISED AUGUST 2008 Questions should be directed to: Ashley Tull (240) 888-7129 or Ronald Zelac (301) 415-7635 or MedicalQuestions.Resource@nrc.gov Licensing

More information

Learning Objectives include:

Learning Objectives include: Organization Frederick Memorial Hospital Solution Title Using Lean to Improve Quality Outcomes DVT Case Study Program/Project Description, including Goals: Hospital Acquired DVTs have become a very serious

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Clinical Policy: Filgrastim, Filgrastim-sndz, Tbo-filgrastim Reference Number: CP.PHAR.297

Clinical Policy: Filgrastim, Filgrastim-sndz, Tbo-filgrastim Reference Number: CP.PHAR.297 Clinical Policy: Reference Number: CP.PHAR.297 Effective Date: 12/16 Last Review Date: 10/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and

More information

AMMONIUM NITRATE LIQUOR, 83%

AMMONIUM NITRATE LIQUOR, 83% Aqueous Ammonium Nitrate Ammonium Nitrate Liquor, 83% MATERIAL SAFETY DATA SHEET AMMONIUM NITRATE LIQUOR, 83% Aqueous Ammonium Nitrate Product Specifications provided by Coastal Chem, Inc. A Subsidiary

More information

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States.

Platelet Concentrate in Total Knees BIOLOGICS. This brochure is for International use only. It is not for distribution in the United States. Platelet Concentrate in Total Knees BIOLOGICS This brochure is for International use only. It is not for distribution in the United States. Platelet Concentrate in Total Knees Total Knee Arthroplasty Total

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

Material Safety Data Sheet

Material Safety Data Sheet Material Safety Data Sheet 28 Jan 2012 Version 1.0 Material Safety Data Sheet Dulbecco's Phosphate Buffered Saline (DPBS) x10 concentrate without Calcium and Magnesium. Section 1 - Product and Company

More information

Doctor of Pharmacy Course Descriptions

Doctor of Pharmacy Course Descriptions Doctor of Pharmacy Course Descriptions Required Courses Pharmacy Practicum II (7002) Second practicum with direct instruction by an experienced preceptor to increase the student's awareness of the pharmacist's

More information

Treatment: Nutrition and Medication

Treatment: Nutrition and Medication INFLAMMATORY BOWEL DISEASE (IBD): CROHN S DISEASE Treatment: Nutrition and Medication While there is no cure for Crohn s disease, there are a number of options to help treat it. The goals of treatment

More information

/ -% I%odand Drug Admlnistretion Center far Bioiogiu3 Evaluation and Reseerch 1401 Rockville f3ke Rockville MD CBER

/ -% I%odand Drug Admlnistretion Center far Bioiogiu3 Evaluation and Reseerch 1401 Rockville f3ke Rockville MD CBER / -% k[l5!( DEPARTMENT OF HEALTH & HUMAN SERVICES PubIiiHealthSenkeJ CBER-01-020 I%odand Drug Admlnistretion Center far Bioiogiu3 Evaluation and Reseerch 1401 Rockville f3ke Rockville MD 20852-1448 April

More information

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work.

Protocol. This trial protocol has been provided by the authors to give readers additional information about their work. Protocol This trial protocol has been provided by the authors to give readers additional information about their work. Protocol for: Hemmelgarn BR, Moist LM, Lok CE, et al. Prevention of dialysis catheter

More information

SAFETY DATA SHEET. Qualitek Everkleen 1005 Buffered Saponifier. MANUFACTURER 24 HR. EMERGENCY TELEPHONE NUMBERS Qualitek International, Inc.

SAFETY DATA SHEET. Qualitek Everkleen 1005 Buffered Saponifier. MANUFACTURER 24 HR. EMERGENCY TELEPHONE NUMBERS Qualitek International, Inc. Page 1 of 6 1. PRODUCT AND COMPANY IDENTIFICATION PRODUCT NAME: PRODUCT DESCRIPTION: Saponifier MANUFACTURER 24 HR. EMERGENCY TELEPHONE NUMBERS Qualitek International, Inc. 1-800-535-5053 Infotrac 315

More information

ChemoLock. Setting a Whole New Standard for Hazardous Drug Safety. Don t you love it when everything just clicks? Introducing

ChemoLock. Setting a Whole New Standard for Hazardous Drug Safety. Don t you love it when everything just clicks? Introducing Introducing ChemoLock Needlefree Closed System Transfer Device The first and only needlefree CSTD to receive FDA 510(k) clearance for both pharmacy (ONB) and patient administration (FPA) applications.

More information

PRODUCT ID: ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION

PRODUCT ID: ARTICAINE HYDROCHLORIDE AND EPINEPHRINE INJECTION SECTION 15: REGULATORY INFORMATION This product has been classified in accordance with the hazard criteria of the Controlled Products Regulations and the MSDS contains all the information required by the

More information

NON-Hazardous Chemical, NON-Dangerous Goods

NON-Hazardous Chemical, NON-Dangerous Goods NON-Hazardous Chemical, NON-Dangerous Goods 1. MATERIAL AND SUPPLY COMPANY IDENTIFICATION Product name: Wood/Plastic Composite Decking Material Recommended use: For decking and screening. Supplier: ModWood

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 7 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Animal Health Pfizer Inc 235 East 42nd Street New York, NY 10017 Poison Control Center Phone: 1-866-531-8896

More information

Material Safety Data Sheet Potassium phosphate dibasic MSDS

Material Safety Data Sheet Potassium phosphate dibasic MSDS Material Safety Data Sheet Potassium phosphate dibasic MSDS Section 1: Chemical Product and Company Identification Product Name: Potassium phosphate dibasic Catalog Codes: SLP1810, SLP2605 CAS#: 7758-11-4

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 8 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

SECTION 2 - GENERAL COMPOSITION OF TONER CONTAINED IN CARTRIDGE. COMPONENT PERCENT CAS# OSHA PEL ACGIH TLV (wt.)

SECTION 2 - GENERAL COMPOSITION OF TONER CONTAINED IN CARTRIDGE. COMPONENT PERCENT CAS# OSHA PEL ACGIH TLV (wt.) TOSHIBA MATERIAL SAFETY DATA SHEET TOSHIBA e-studio 220P Print Cartridge Revised date: 4/24/03 Toshiba has determined that Material Safety Data Sheets are not required for print cartridges. For customer

More information

Using Complete Blood Cell Counts to Diagnose Disease

Using Complete Blood Cell Counts to Diagnose Disease Physiology 2 Redwood High School Name Class Period Using Complete Blood Cell Counts to Diagnose Disease Background A healthy adult has about 4.5 to 5 million red blood cells and approximately 8,000 white

More information

SAFETY DATA SHEET. ResistAll EnviroGuard Next Generation NG Vinyl/Leather Sealant

SAFETY DATA SHEET. ResistAll EnviroGuard Next Generation NG Vinyl/Leather Sealant Page 1 of 5 SAFETY DATA SHEET ResistAll EnviroGuard Next Generation NG Vinyl/Leather Sealant Date Prepared : 12/01/2014 MSDS No : R/A-L/V-NG fmc Date Revised : 05/29/2015 Revision No : 1 1. PRODUCT AND

More information

Ammonia solution, aqueous ammonia, ammonia water, Spirits of Hartshorn. Chemical Name CAS # RTEC #

Ammonia solution, aqueous ammonia, ammonia water, Spirits of Hartshorn. Chemical Name CAS # RTEC # M A T E R I A L S A F E T Y D A T A S H E E T SECTION I. PRODUCT IDENTIFICATION WESTERN FARM SERVICE 3705 W. Beechwood Ave. P.O. Box 1168 Fresno, CA 93715 (209) 436-0450 FAX (209)436-0515 MATERIAL SAFETY

More information

Safety Data Sheet. Issuing date: 03/02/2015 Revision date: 02/22/2017 Revision number: 01

Safety Data Sheet. Issuing date: 03/02/2015 Revision date: 02/22/2017 Revision number: 01 1. Identification of the substance/preparation and the company/undertaking GHS product identifier Product name: Sodium Citrate and Citric Acid Oral Solution USP Other mean of identification Product code(s):

More information

SAFETY DATA SHEET. Emergency Response INFOTRAC (USA) INFOTRAC (International)

SAFETY DATA SHEET. Emergency Response INFOTRAC (USA) INFOTRAC (International) January 23, 2015 SAFETY DATA SHEET Emergency Response 800-535-5053 INFOTRAC (USA) +1-352-323-3500 INFOTRAC (International) Section 1. Product and Company Identification Young Nails Rose Cuticle Oil Distributor:

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET Issue Date: 1/1/2015 Version: 2.0 Section 1 Product Name Product Use Product and Company Information ProKure D Deodorizing delivery system (pouch) for the generation of chlorine

More information

Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research Hospital in Turkey

Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research Hospital in Turkey VOLUME 8 NUMBER 3 September 2017 JOURNAL OF CLINICAL AND EXPERIMENTAL INVESTIGATIONS ORIGINAL ARTICLE Use of Heparin and The Related Incidence of Heparin- Induced Thrombocytopenia in an Education and Research

More information

2. QUALITATIVE AND QUANTITATIVE COMPOSITION

2. QUALITATIVE AND QUANTITATIVE COMPOSITION 1. NEUPOGEN Neupogen 300 mcg/ml solution for injection vial Neupogen 300 mcg/0.5ml solution for injection pre-filled syringe (not available) Neupogen 480 mcg/0.5ml solution for injection pre-filled syringe

More information

HAZARDOUS MATERIALS 7/7/2016 OR THE RIGHT-TO-KNOW HAZARD COMMUNICATION STANDARD (HCS) DISCLAIMER

HAZARDOUS MATERIALS 7/7/2016 OR THE RIGHT-TO-KNOW HAZARD COMMUNICATION STANDARD (HCS) DISCLAIMER HAZARD COMMUNICATION STANDARD (HCS) HAZARDOUS MATERIALS SAFE HANDLING Passed by Congress in 1988 with feedback from National Institute for Occupational Safety and Health (NIOSH) United States Pharmacopeia

More information

Cancer Vanguard. Biosimilars Trust Policy Template

Cancer Vanguard. Biosimilars Trust Policy Template Cancer Vanguard Biosimilars Trust Policy Template Aim of this document: The document provides generic guidance and outline for the development of local trust policies in relation to the adoption of biosimilars

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET 1 PRODUCT AND COMPANY IDENTIFICATION Product Name: Snake-A-Way Synonyms: Not applicable Molecular Formula: Not applicable Molecular Weight: Not applicable Product Number: FIN

More information

Material Safety Data Sheet

Material Safety Data Sheet Material Safety Data Sheet NFPA HMIS Personal Protective Equipment 1 Health Hazard Fire Hazard 1 See Section 15. Section 1. Chemical Product and Company Identification Common Name/ Trade Name Manufacturer

More information

Introduction. This booklet also highlights ways to minimise the potential risks associated with micafungin use.

Introduction. This booklet also highlights ways to minimise the potential risks associated with micafungin use. 1 2 Introduction This booklet for prescribers and nurses provides practical guidance on the safe use and administration of micafungin, an echinocandin antifungal drug. This booklet also highlights ways

More information

Dysprosium (III) Fluoride [DyF 3 ]

Dysprosium (III) Fluoride [DyF 3 ] STANDARD OPERATING PROCEDURE Dysprosium (III) Fluoride [DyF 3 ] (Prepared by Ryan Chesser, Oct. 2015) According to the Safety Data Sheet (SDS) special precautions must be taken when working with the chemical

More information

Strontium Iron Oxide Nanoparticles (SrFe12O19) US Research Nanomaterials, Inc. Material Safety Data Sheet acc. to OSHA and ANSI

Strontium Iron Oxide Nanoparticles (SrFe12O19) US Research Nanomaterials, Inc. Material Safety Data Sheet acc. to OSHA and ANSI Strontium Iron Oxide Nanoparticles (SrFe12O19) US Research Nanomaterials, Inc. Material Safety Data Sheet acc. to OSHA and ANSI 1 Identification of substance: Product details: Product name: Strontium dodecairon

More information

Material Safety Data Sheet

Material Safety Data Sheet Rod Grease Tacky I. PRODUCT AND COMPANY IDENTIFICATION Product Name: Rod Grease Tacky Revised: 7/2010 Chemical Name: Petroleum Lubricating Grease Chemical Family: Hydrocarbon Supplier: NOV FluidControl

More information

Material Safety Data Sheet October 2012

Material Safety Data Sheet October 2012 Material Safety Data Sheet October 2012 Section 1 Chemical Product and Company Identification Trade Name: Chemical Name: Formula: Manufacturer: So-Cal Sodium Chloride Brine, Calcium Chloride Brine, with

More information

Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals

Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals Guidelines for the Medical Clearance of Designated Ebola Caregivers in US Hospitals American College of Occupational and Environmental Medicine Medical Center Occupational Health Section Prepared by the

More information

CAS Component Percent Ferrophosphorus 99%

CAS Component Percent Ferrophosphorus 99% * * *Section 1 Identification* * * Product Identifier: Ferrophosphorus Chemical Family: Alloy Recommended Use: Manufacture of iron and steel Restriction on Use: None identified Manufacturer Information

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET Page 1 of 6 1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND THE COMPANY/UNDERTAKING Pfizer Inc Pfizer Pharmaceuticals Group 235 East 42nd Street New York, New York 10017 1-212-573-2222 Emergency telephone

More information

MEDICAL WASTE MANAGEMENT STUDY NOTES

MEDICAL WASTE MANAGEMENT STUDY NOTES MEDICAL WASTE MANAGEMENT STUDY NOTES UNIT 1 INTRODUCTION Hospital and other health care establishment has a duty of care for the environment and for public health and have particular responsibility in

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET MATERIAL SAFETY DATA SHEET This Material Safety Data Sheet meets or exceeds the requirements of the Canadian Controlled Product Regulations (WHMIS) 1. Product and Supplier Identification Product: Broda

More information

Material Safety Data Sheet. FUROSEMIDE INJECTION, USP, 10 mg/ml

Material Safety Data Sheet. FUROSEMIDE INJECTION, USP, 10 mg/ml 1. PRODUCT IDENTIFICATION Common/Trade Name: How Supplied: Chemical Class Chemical Name Furosemide Injection, USP Strength: 10 mg/ml Anthranilic acid derivative Benzoic acid, 5-(aminosulfonyl)-4-chloro-2-

More information

Date Printed: 05/11/2004 Date Updated: 04/04/2004 Version 1.8. Product Name MAGNESIUM SULFATE, 97+% Product Number

Date Printed: 05/11/2004 Date Updated: 04/04/2004 Version 1.8. Product Name MAGNESIUM SULFATE, 97+% Product Number SIGMA-ALDRICH MATERIAL SAFETY DATA SHEET Date Printed: 05/11/2004 Date Updated: 04/04/2004 Version 1.8 Section 1 - Product and Company Information Product Name MAGNESIUM SULFATE, 97+% Product Number 208094

More information

RITUXAN(R) Vials (100 mg/10 ml)

RITUXAN(R) Vials (100 mg/10 ml) Safety Data Sheet RITUXAN(R) Vials (100 mg/10 ml) SECTION 1: Identification of the substance/mixture and of the company/undertaking 1.1. Product identifier Product name Product code Synonyms RITUXAN(R)

More information

Daratumumab (Darzalex )

Daratumumab (Darzalex ) Daratumumab (Darzalex ) This Horizons Infosheet contains information on daratumumab (also known as Darzalex), a drug being investigated for the treatment of myeloma. The Horizons Infosheet series provides

More information

MSDS FOR ZINC METAL: PRIME WESTERN

MSDS FOR ZINC METAL: PRIME WESTERN SECTION I - GENERAL INFORMATION NAME: ZINC METAL MANUFACTURER: TRANSPORTATION EMERGENCY: HORSEHEAD CORPORATION CHEMTREC: 800-424-9300 300 Frankfort Road Monaca, PA 15061 724-774-1020 CHEMICAL FAMILY: Nonferrous

More information

ANAPROX(R) Tablets (550 mg)

ANAPROX(R) Tablets (550 mg) Material Safety Data Sheet ANAPROX(R) Tablets (550 mg) 1. Product and Company Identification Product name ANAPROX(R) Tablets (550 mg) Product code 09 8510 4 Use Company information Anaprox is a nonsteroidal

More information

MATERIAL SAFETY DATA SHEET

MATERIAL SAFETY DATA SHEET 1. Product and Company Identification Material name Product Code 98668775 Version # 04 Revision date 04-06-2011 MATERIAL SAFETY DATA SHEET Clean Quick Chlorine Sanitizer Manufacturer Procter & Gamble Professional

More information

TREATMENT OVERVIEW themmrf.org

TREATMENT OVERVIEW themmrf.org MULTIPLE MYELOMA TREATMENT OVERVIEW themmrf.org ABOUT THE MULTIPLE MYELOMA RESEARCH FOUNDATION The Multiple Myeloma Research Foundation (MMRF) was established in 1998 by identical twin sisters Kathy Giusti

More information

Anti- THrombosis with Enoxaparin in intubated Adolescents

Anti- THrombosis with Enoxaparin in intubated Adolescents Anti- THrombosis with Enoxaparin in intubated Adolescents E. Vincent S. Faustino, MD, MHS October 2017 NHLBI submission S L I D E 0 Research question, central hypothesis and primary aim Research Question

More information

Guidelines for the Use of Cytotoxic or Chemotherapeutic Drugs

Guidelines for the Use of Cytotoxic or Chemotherapeutic Drugs Guidelines for the Use of Cytotoxic or Chemotherapeutic Drugs Caltech Environment, Health and Safety 1200 E. California Blvd. M/C 25-6 Pasadena, CA 91125 626.395.6727 safety@caltech.edu www.safety.caltech.edu

More information

Initial Dose 10,000 units Every 4 to 6 hours 5,000 to 10,000 units. Intermittent IV injection

Initial Dose 10,000 units Every 4 to 6 hours 5,000 to 10,000 units. Intermittent IV injection HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use HEPARIN SODIUM IN 0.45% SODIUM CHLORIDE INJECTION safely and effectively. See full prescribing information

More information

Cemented Carbide Article (Sintered WC + Co)

Cemented Carbide Article (Sintered WC + Co) Cemented Carbide Article (Sintered WC + Co) Safety Data Sheet Revision Date: 27-May-2015 Supersedes: January 2008 Version: 2.0 Product Identifier / Other Means of Identification Product Name / Identifier

More information

Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking

Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Function, Action and Interference of Anti-CD38 (DARA) Antibody in Blood Banking Joy Gould BB(ASCP)C, SBB, CQIA(ASQ), CPHQ Thomas Jefferson University Hospital Philadelphia, PA Objectives Define Multiple

More information

Safety Data Sheet Spartan Chemical Company, Inc.

Safety Data Sheet Spartan Chemical Company, Inc. Safety Data Sheet Spartan Chemical Company, Inc. Revision Date: 30-Jul-2015 1. PRODUCT AND COMPANY IDENTIFICATION Product Identifier Product Name: ASAP Product Number: 3190 Recommended Use: Cleaning agent

More information